Drulis-Kawa Z - Search Results

1

Phages and phage-borne enzymes as new antibacterial agents.

McCallin S, Drulis-Kawa Z, Ferry T, Pirnay JP, Nir-Paz R; ESGNTA – ESCMID study group for non-traditional antibacterials. McCallin S, et al. Among authors: drulis kawa z. Clin Microbiol Infect. 2023 Oct 20:S1198-743X(23)00528-1. doi: 10.1016/j.cmi.2023.10.018. Online ahead of print. Clin Microbiol Infect. 2023. PMID: 37866680 Review.

2

Multifunctional lanthanide and silver ion co-doped nano-chlorapatites with combined spectroscopic and antimicrobial properties.

Wiglusz RJ, Drulis-Kawa Z, Pazik R, Zawisza K, Dorotkiewicz-Jach A, Roszkowiak J, Nedelec JM. Wiglusz RJ, et al. Dalton Trans. 2015 Apr 21;44(15):6918-25. doi: 10.1039/c5dt00046g. Dalton Trans. 2015. PMID: 25777982

3

[The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].

Drulis-Kawa Z, Weber-Dabrowska B, Lewczyk E, Jankowski S, Doroszkiewicz W. Drulis-Kawa Z, et al. Pol Merkur Lekarski. 2002 Dec;13(78):470-2. Pol Merkur Lekarski. 2002. PMID: 12666443 Polish.

4

Human body morphology, prevalence of nasopharyngeal potential bacterial pathogens, and immunocompetence handicap principal.

Pawlowski B, Nowak J, Borkowska B, Drulis-Kawa Z. Pawlowski B, et al. Am J Hum Biol. 2014 May-Jun;26(3):305-10. doi: 10.1002/ajhb.22510. Epub 2014 Feb 12. Am J Hum Biol. 2014. PMID: 24519962

5

Liposomes as delivery systems for antibiotics.

Drulis-Kawa Z, Dorotkiewicz-Jach A. Drulis-Kawa Z, et al. Int J Pharm. 2010 Mar 15;387(1-2):187-98. doi: 10.1016/j.ijpharm.2009.11.033. Epub 2009 Dec 5. Int J Pharm. 2010. PMID: 19969054 Review.

6

Hydrolytic activity determination of Tail Tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates.

Brzozowska E, Pyra A, Pawlik K, Janik M, Górska S, Urbańska N, Drulis-Kawa Z, Gamian A. Brzozowska E, et al. Sci Rep. 2017 Dec 22;7(1):18048. doi: 10.1038/s41598-017-18096-1. Sci Rep. 2017. PMID: 29273737 Free PMC article.

7

Isolation and characterisation of KP34--a novel φKMV-like bacteriophage for Klebsiella pneumoniae.

Drulis-Kawa Z, Mackiewicz P, Kęsik-Szeloch A, Maciaszczyk-Dziubinska E, Weber-Dąbrowska B, Dorotkiewicz-Jach A, Augustyniak D, Majkowska-Skrobek G, Bocer T, Empel J, Kropinski AM. Drulis-Kawa Z, et al. Appl Microbiol Biotechnol. 2011 May;90(4):1333-45. doi: 10.1007/s00253-011-3149-y. Epub 2011 Feb 16. Appl Microbiol Biotechnol. 2011. PMID: 21327407 Free PMC article.

8

In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.

Drulis-Kawa Z, Gubernator J, Dorotkiewicz-Jach A, Doroszkiewicz W, Kozubek A. Drulis-Kawa Z, et al. Int J Pharm. 2006 Jun 6;315(1-2):59-66. doi: 10.1016/j.ijpharm.2006.02.017. Epub 2006 Mar 6. Int J Pharm. 2006. PMID: 16551496

9

Characterization of five novel endolysins from Gram-negative infecting bacteriophages.

Walmagh M, Boczkowska B, Grymonprez B, Briers Y, Drulis-Kawa Z, Lavigne R. Walmagh M, et al. Appl Microbiol Biotechnol. 2013 May;97(10):4369-75. doi: 10.1007/s00253-012-4294-7. Epub 2012 Jul 26. Appl Microbiol Biotechnol. 2013. PMID: 22832988

10

Bactericidal properties of silica particles with silver islands located on the surface.

Bugla-Płoskońska G, Leszkiewicz A, Borak B, Jasiorski M, Drulis-Kawa Z, Baszczuk A, Maruszewski K, Doroszkiewicz W. Bugla-Płoskońska G, et al. Int J Antimicrob Agents. 2007 Jun;29(6):746-8. doi: 10.1016/j.ijantimicag.2006.09.022. Epub 2007 Feb 1. Int J Antimicrob Agents. 2007. PMID: 17275262 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page